Profile
Sector:
HealthcareIndustry:
Health Information ServicesCountry:
United StatesIPO:
25 October 2019Website:
http://www.progyny.comNext earnings report:
12 November 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | 56 min agoDividend
Analysts recommendations
Institutional Ownership
PGNY Latest News
NEW YORK, NY / ACCESSWIRE / November 4, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK , Nov. 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, NY / ACCESSWIRE / October 31, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the quarterly period ended September 30, 2024 after the close of the market on Tuesday, November 12, 2024.
NEW YORK, NY / ACCESSWIRE / October 27, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK , Oct. 25, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
SAN FRANCISCO, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Fertility benefits provider Progyny, Inc. (NASDAQ: PGNY) is under intense scrutiny following the unexpected announcement of a major client's departure.
NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ:PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
NEW YORK , Oct. 17, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Progyny, Inc. ("Progyny" or the "Company") (NASDAQ: PGNY). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
PGNY Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCICSO, CA / ACCESSWIRE / October 16, 2024 / Hagens Berman urges Progyny, Inc. (NASDAQ:PGNY) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys.
What type of business is Progyny?
Progyny, Inc. is an American company specializing in managing benefits in the field of reproductive health. Previously known as Auxogyn, Inc., the company changed its name to Progyny, Inc. in 2015. Progyny, Inc. was registered in 2008, with its headquarters located in New York, New York. The company offers the Smart Cycle treatment package, which includes all necessary diagnostic tests and access to the latest technologies (such as preimplantation genetic testing in the case of IVF treatment). Smart Cycle provides 17 different procedure packages that can be used independently or in combination, depending on the participant's needs. The company also offers Progyny Rx - a comprehensive pharmacy benefit solution that provides participants with access to medications needed during their treatment.
What sector is Progyny in?
Progyny is in the Healthcare sector
What industry is Progyny in?
Progyny is in the Health Information Services industry
What country is Progyny from?
Progyny is headquartered in United States
When did Progyny go public?
Progyny initial public offering (IPO) was on 25 October 2019
What is Progyny website?
https://www.progyny.com
Is Progyny in the S&P 500?
No, Progyny is not included in the S&P 500 index
Is Progyny in the NASDAQ 100?
No, Progyny is not included in the NASDAQ 100 index
Is Progyny in the Dow Jones?
No, Progyny is not included in the Dow Jones index
When was Progyny the previous earnings report?
No data
When does Progyny earnings report?
The next expected earnings date for Progyny is 12 November 2024